CUBT — Curative Biotechnology Inc
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1400271 ·
Last close
$1.00
Market Cap
$8.89M
52W High
$1.99
52W Low
$0.03
ADV30
708
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2022 | 0 | -4,435,688 | -5,604,893 | 2,089,191 | 22,618,928 | -20,529,737 | -1,535,573 |
| Dec 2021 | 0 | -4,997,374 | -5,340,354 | 2,412,150 | 18,773,892 | -16,361,742 | -1,604,035 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SNTI | Senti Biosciences Holdings, Inc. | $10.25M | $0.33 | — |
| ZEOX | Zeo ScientifiX, Inc. | $10.66M | $1.36 | — |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | $10.70M | $0.97 | — |
| AIM | AIM ImmunoTech Inc. | $7.11M | $0.19 | — |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | $6.79M | $1.03 | — |
News headlines (Yahoo Finance, 1h cache)
Curative Biotechnology, Inc. Issues Letter to Shareholders
2026-09-11 11:00 · Yahoo
Curative Biotechnology Announces U.S. Patent Allowance Strengthening Core Ophthalmology Platform
2026-07-16 11:00 · Yahoo
Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement
2026-05-07 11:00 · Yahoo
Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting
2026-03-23 23:05 · Yahoo
Curative Biotech announces Canadian patent allowance
2026-01-24 13:50 · Yahoo
Curative Biotechnology Announces Canadian Patent Allowance
2026-01-23 13:45 · Yahoo
Curative Biotechnology, Inc. Announces Letter to Shareholders
2025-11-18 13:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.